SÖSimge Çınar Özel

Simge Çınar Özel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Simge Çınar Özel has a total of 81 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Transient abnormal myelopoiesis in down syndrome: Turkish society of pediatric hematology data

    by Yeter Düzenli Kar, Hale Ören, Emine Zengin, Nazan Sarper, Simge Çınar Özel, Burcu Kılınç Oktay, Zeliha Güzelküçük, Neşe Yaralı, Zühre Kaya, Zeynep Canan Özdemir, et al.

  • Open Access

    Real-world outcomes of children with first relapsed acute lymphoblastic leukemia treated according to the ALL-IC REL 2016 guideline in Türkiye

    by Volkan Hazar, Adalet Meral Güneş, Hüsniye Neşe Yaralı, Koray Yalçın, Funda Tayfun Küpesiz, Tuba Hilkay Karapınar, Ali Ayçiçek, Emine Zengin, Melike Sezgin Evim, Namık Yaşar Özbek, et al.

  • Open Access

    Wernicke Encephalopathy Induced by Prolonged Total Parenteral Nutrition in a 16-Year-Old Girl with Acute Myeloid Leukemia

    by Eymen Pınar, Burcu Kılınç Oktay, Simge Çınar Özel, Ayşe Gonca Kaçar, Ayşe Kalyoncu Uçar, Osman Kızılkılıç, Alp Özkan, Hilmi Apak, Süheyla Ocak

    Cite this article as: Pınar E, Oktay BK, Özel SC, et al. Wernicke encephalopathy induced by prolonged total parenteral nutrition in a 16-year-old girl with acute myeloid leukemia. Turk Arch Pediatr. 2025;60(5):557-559.

  • Effect of platelet count and platelet transfusion on fever duration in patients with febrile neutropenia

    by Berrak Öztosun, Betül Zehra Pirdal, Simge Çınar Özel, Ayşe Gonca Kaçar, Hilmi Apak, Tiraje Celkan

    Platelets play a role in hemostasis, thrombosis, and vascular integrity. They also play a major role in the development of inflammation and the activation of immune responses. They have phagocytic activity, stimulate the secretion of immune modulators, and activate other immune cells, which results in platelet-neutrophil aggregation, platelet-induced neutrophil degranulation, and the formation of neutrophil extracellular traps. Data on 124 febrile neutropenia attacks were retrospectively examined. Patients’ age, sex, diagnosis, and relapse history were obtained. The complete blood count levels on the first and last febrile day of the febrile neutropenia attacks, duration of fever, and number, type, and timing of thrombocyte suspension transfusions were recorded. The patients were divided into three groups according to the day of fever when the platelet suspension was administered (1 day, 2–3 days, and >3 days); the duration of fever was compared between the three groups. The fever duration of those who were transfused with platelet suspension on the first day of fever was found to be significantly shorter (p = 0.03 and p < 0.001, respectively). When treating a patient with febrile neutropenia, if thrombocyte suspension transfusion is indicated, transfusing thrombocytes in the first days of fever shortens the fever duration and improves the prognosis of febrile neutropenia attack, supporting the hypothesis that not only neutrophils but also platelets may play a role in fighting against microorganisms.


  • Open Access

    Neurofibromatosis Type 1 in Children: A Single-Center Experience

    by Ayşe Gonca Kaçar, Burcu Kılınc Oktay, Simge Çınar Özel, Süheyla Ocak, Nilay Güneş, Dilek Uludağ Alkaya, Beyhan Tüysüz, Hilmi Apak, Tülin Tiraje Celkan

    Objective: Neurofibromatosis (NF) is the most common autosomal dominantly inherited neurocutaneous syndrome. The characteristic features of NF type 1 (NF-1) are café au lait spots, axillary and inguinal freckling, peripheral neurofibromas, optic pathway glioma, and Lisch nodules. The present study aimed to analyze the clinical features of children with NF-1. Materials and Methods: In this study, the children with NF-1 diagnosed and followed-up in our center between 2000 and 2020 were retrospectively evaluated. Demographic and clinical features of patients were defined. Results: The study group consisted of 52 patients. Of those, 25 were boys and 27 were girls. The children’s median age at diagnosis was 5.9 years (1-15.8). Café au lait (CAL) spots and axillary/ inguinal freckling were observed in 50 and 24 patients, respectively. Neurofibroma was present in 22 cases. Ten of the cohort had optic gliomas, and 39 of them had cranial hamartomas. Orthopedic complications such as scoliosis, tibial pseudoarthrosis, and osteoporosis were observed in 13 patients. Eleven children had neurocognitive disorders. Conclusions: Early diagnosis is important in neurofibromatosis to prevent the complications of the disease. Also, neurological development and secondary malignancy follow-up should be done carefully in this group of patients. Cite this article as: Kaçar AG, Kılınc Oktay B, Çınar Özel S, et al. Neurofibromatosis type 1 in children: A single-center experience. Turk Arch Pediatr. 2021; 56(4): 339-343.


  • Open Access

    Clinical course of pediatric large vascular anomalies located in the extremities

    by Burcu Kılınç Oktay, Ayşe Gonca Kaçar, Simge Çınar Özel, Süheyla Ocak, Tiraje Celkan

    Objective: Difficulties encountered in the diagnosis and treatment of vascular anomalies located in the extremities of the children. The most common vascular lesions are hemangiomas and venous malformations. The complex malformations, such as, Klippel-Trenaunay Syndrome are much less commonly encountered lesions. Treatment of vascular malformations are variable based on the etiology of the lesion and clinical presentation. In this study, we aimed to share our experience on the clinical features of vascular lesions in the extremities of the children. Material and Methods: The demographic, clinical and prognostic features of 330 children with vascular anomalies followed at IUC, Cerrahpasa Medical Faculty, Department of Pediatric Hematology and Oncology were retrospectively reviewed. Fifty-one patients with lesions >5 cm in diameter were included into the study. The diagnosis, age, sex, history of prematurity, lesion type and location, imaging and biopsy findings, complications, details of treatment, and follow-up were evaluated. Results: Twenty-nine (57%) of patients were female and 22 (43%) were male. The female to male ratio was 1.3:1. The median age at admission was 15 months (10 days-180 months). Eight patients (16%) had a history of premature birth. Thirty-one patients (61%) had lesions since birth, eight lesions (8%) appeared in the first month of life and 6 (12%) occurred after 1 year of age. Sixteen of the patients (31%) had hemangioma, 11 (22%) had lymphangioma, 19 (37%) had venous malformation and 5 (10%) were diagnosed as Klippel Trenaunay Syndrome. The lesions were in the upper extremity in 21 patients (41%), in the lower extremity in 27 patients (53%), and both lower and upper extremities were affected in 3 patients (6%). Of all patients, six had intramuscular and two had intraarticular lesions. The diagnosis was made on clinical grounds in most of the cases. In 22 children Magnetic Resonance Imaging was performed for differential diagnosis and to demonstrate the infrastructure of the lesion and the extent of local infiltration. Histopathologic examination by biopsy was done in four patients. Complications developed in 19 patients as follows: Disseminated intravascular coagulation in 6, bleeding in 4, thrombosis in 3, and soft tissue infection in 6. Twenty-one patients were not given any treatment. Medical treatments were propranolol in 14 patients, sirolimus in 4 patients, propranolol and sirolimus in 5 patients. Intralesional bleomycin injection was performed in 3 children. Conclusion: The diagnosis, classification and treatment of extremity located vascular malformations in children are complex. Treatment strategy should be defined as in accordance with a combination of the type of the vascular malformation, the age of the patient and the clinical picture. Cite this article as: Oktay BK, Kaçar AG, Özel SG, Ocak S, Celkan T. Clinical course of pediatric large vascular anomalies located in the extremities. Turk Arch Pediatr 2021; 56(3): 213-8.


  • Open Access

    OUTCOMES OF ELTROMBOPAG TREATMENT AND DEVELOPMENT OF IRON DEFICIENCY IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA IN TURKEY

    by Ayça Koca Yozgat, Göksel Leblebisatan, Sinan Akbayram, Simge Çınar Özel, Zeynep Karakaş, Erol Erduran, Şebnem Yılmaz, Ülker Koçak, Şule Ünal, Gül Nihal Özdemir, et al.

    Objective: Immune thrombocytopenia (ITP) is a rare autoimmune disease and hematologic disorder characterized by reduced platelet counts that can result in significant symptoms, such as bleeding, bruising, epistaxis, or petechiae. The thrombopoietin receptor agonist eltrombopag (EPAG) is a second-line agent used to treat chronic ITP purpura in adults and children. Materials and Methods: The present retrospective study evaluated the efficacy, safety, and side effects of EPAG treatment in pediatric patients with acute refractory and chronic immune thrombocytopenia, particularly focusing on iron-deficiency anemia. Results: The diagnosis was chronic ITP in 89 patients and acute refractory ITP in 16 patients. The mean age of patients was 9.5 +/- 4.5 years (minimum-maximum: 1.2-18 years) at the beginning of EPAG treatment. The overall response rate was 74.3% (n=78). The mean time for platelet count of >= 50x109/L was 11.6 +/- 8 weeks (range: 1-34 weeks). The treatment was stopped for 27 patients (25.7%) at an average of 6.8 +/- 9 months (range: 1-38 months). The reason for discontinuation was lack of response in 18 patients, nonadherence in 4 patients, and hepatotoxicity in 2 patients. Response to treatment continued for an average of 4 months after cessation of EPAG in 3 patients. Conclusion: Results of the current study imply that EPAG is an effective therapeutic option in pediatric patients with acute refractory and chronic ITP. However, patients must be closely monitored for response and side effects during treatment, and especially for iron deficiency.